http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115019932-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a07bc3cf4400a7099cc076f54f23ddf |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-20 |
| filingDate | 2022-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41105e85892fe18eee213e3eae810d5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84d4b57a1bccbfa9851e32fb703c980e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2faf092998c63e0f15c7a0dcf82e1df1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5909f11595c62cc49f6fbb03754801a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79856bf72e92416ee380561b6908139d |
| publicationDate | 2022-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-115019932-A |
| titleOfInvention | System and method for predicting the dose of exogenous follicle-stimulating hormone administered in a COS cycle |
| abstract | A system for predicting the dose of exogenous FSH administered to a subject in a COS cycle is disclosed, comprising: a data acquisition module for obtaining subject age, basal AMH, basal FSH or ΔINHB, basal AFC data; exogenous The sexual FSH drug dose calculation module is used to: perform the first calculation on the obtained data, and calculate the predicted NROs of the subject; perform the second calculation on the obtained data, calculate the predicted NROs of the subject and give the test subjects. The ratio of the exogenous FSH drug dose to the patients; based on the first calculated predicted NROs and this ratio, the exogenous FSH drug dose to be administered was calculated. A corresponding prediction method is also disclosed. The present application calculates the predicted NROs first, and then calculates the predicted ovarian sensitivity, that is, the ratio of the predicted NROs to the exogenous FSH drug dose, and then obtains the exogenous FSH drug dose. Among the outcome variables for predicting ovarian sensitivity, only exogenous FSH drugs are administered. Exogenous FSH drug dose was predicted with an unknown variable for exogenous FSH drug dose, with a model R 2 >0.9. |
| priorityDate | 2022-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.